Drug Shortage Report for GLN-URSODIOL

Last updated on 2025-05-08 History
Report ID 247163
Drug Identification Number 02426919
Brand name GLN-URSODIOL
Common or Proper name Ursodiol
Company Name GLENMARK PHARMACEUTICALS CANADA INC.
Market Status MARKETED
Active Ingredient(s) URSODIOL
Strength(s) 500MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging sizes (GTIN)

Click here to see a list of all reports for this drug.

(See additional packaging sizes)
Additional packaging sizes 100 tablets
ATC code A05AA
ATC description BILE THERAPY
Reason for shortage Demand increase for the drug.
Anticipated start date 2025-01-08
Actual start date 2025-01-08
Estimated end date 2025-05-05
Actual end date 2025-05-05
Shortage status Resolved
Updated date 2025-05-08
Company comments Product is on allocation at the customer level. This may result in shortages in certain locations.
Health Canada comments
Tier 3 Status No
Contact Address 1600 STEELES AVE. W., SUITE 407
CONCORD, ONTARIO
CANADA L4K 4M2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2025-05-08 French Compare
v12 2025-05-08 English Compare
v11 2025-04-28 French Compare
v10 2025-04-28 English Compare
v9 2025-04-02 French Compare
v8 2025-04-02 English Compare
v7 2025-03-06 French Compare
v6 2025-03-06 English Compare
v5 2025-02-11 French Compare
v4 2025-02-11 English Compare
v3 2025-01-09 English Compare
v2 2025-01-08 French Compare
v1 2025-01-08 English Compare

Showing 1 to 13 of 13